JP2023502423A - 食物アレルギー経口免疫療法薬物の配給及び治療を管理する方法及びシステム - Google Patents

食物アレルギー経口免疫療法薬物の配給及び治療を管理する方法及びシステム Download PDF

Info

Publication number
JP2023502423A
JP2023502423A JP2022529341A JP2022529341A JP2023502423A JP 2023502423 A JP2023502423 A JP 2023502423A JP 2022529341 A JP2022529341 A JP 2022529341A JP 2022529341 A JP2022529341 A JP 2022529341A JP 2023502423 A JP2023502423 A JP 2023502423A
Authority
JP
Japan
Prior art keywords
patient
information
drug
management database
registration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022529341A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023502423A5 (https=
Inventor
エイドリアン ダナ，
ダニエル アデルマン，
Original Assignee
ソシエテ・デ・プロデュイ・ネスレ・エス・アー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ソシエテ・デ・プロデュイ・ネスレ・エス・アー filed Critical ソシエテ・デ・プロデュイ・ネスレ・エス・アー
Publication of JP2023502423A publication Critical patent/JP2023502423A/ja
Publication of JP2023502423A5 publication Critical patent/JP2023502423A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/60—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/20—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H80/00—ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Primary Health Care (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Data Mining & Analysis (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Databases & Information Systems (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2022529341A 2019-11-20 2020-11-19 食物アレルギー経口免疫療法薬物の配給及び治療を管理する方法及びシステム Pending JP2023502423A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962938180P 2019-11-20 2019-11-20
US62/938,180 2019-11-20
US202063056492P 2020-07-24 2020-07-24
US63/056,492 2020-07-24
PCT/US2020/061362 WO2021102186A1 (en) 2019-11-20 2020-11-19 Methods and systems for managing distribution and treatment of a food allergy oral immunotherapy drug

Publications (2)

Publication Number Publication Date
JP2023502423A true JP2023502423A (ja) 2023-01-24
JP2023502423A5 JP2023502423A5 (https=) 2023-11-29

Family

ID=75909665

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022529341A Pending JP2023502423A (ja) 2019-11-20 2020-11-19 食物アレルギー経口免疫療法薬物の配給及び治療を管理する方法及びシステム

Country Status (8)

Country Link
US (2) US20220415464A1 (https=)
EP (1) EP4061753A4 (https=)
JP (1) JP2023502423A (https=)
CN (1) CN114981191B (https=)
AU (1) AU2020388398A1 (https=)
BR (1) BR112022009664A2 (https=)
CA (1) CA3162233A1 (https=)
WO (1) WO2021102186A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022003604A1 (en) 2020-07-01 2022-01-06 Société des Produits Nestlé S. A. Determining medical staffing for oral immunotherapy
US12100510B2 (en) 2022-10-10 2024-09-24 CareMetx, LLC System and method for enrollment into patient service programs

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8386274B1 (en) * 2008-09-17 2013-02-26 Mckesson Financial Holdings Limited Systems and methods for a prescription safety network utilizing eligibility verification transactions
US20130292294A1 (en) * 2012-05-03 2013-11-07 Brandon J. Wilson Allergy emergency kit
JP2014509606A (ja) * 2011-03-17 2014-04-21 ケンブリッジ エンタープライズ リミティッド ピーナッツアレルギーの治療
JP2016512537A (ja) * 2013-03-14 2016-04-28 アイミューン セラピューティクス，インコーポレイテッド 経口脱感作のための落花生処方物の製造
JP2016521713A (ja) * 2013-06-04 2016-07-25 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． Ｉｌ−４ｒ阻害剤の投与によるアレルギー処置方法およびアレルゲン特異的免疫療法の向上方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5797515A (en) * 1995-10-18 1998-08-25 Adds, Inc. Method for controlling a drug dispensing system
US20090019552A1 (en) * 2000-03-15 2009-01-15 Mclaughlin Mark R Healthcare Medical Information Management System
US7668730B2 (en) * 2002-12-17 2010-02-23 JPI Commercial, LLC. Sensitive drug distribution system and method
WO2008021954A2 (en) * 2006-08-09 2008-02-21 Biogen Idec Ma Inc. Method for distribution of a drug
CA2616511C (en) * 2007-07-06 2017-11-07 Catalyst Healthcare Ltd. Medication dose administration and inventory management
WO2010104841A2 (en) * 2009-03-09 2010-09-16 Celgene Corporation Device for delivering a drug to a patient while restricting access to the drug by patients for whom the drug may be contraindicated and methods for use thereof
US8392219B1 (en) * 2010-05-10 2013-03-05 Mckesson Financial Holdings Limited Systems and methods for streamlined patient enrollment for one or more healthcare programs
CA2807949C (en) * 2010-08-13 2022-10-25 Intellimedicine, Inc. System and methods for the production of personalized drug products
EP2617296A1 (en) * 2012-01-19 2013-07-24 Nestec S.A. A composition comprising specific Lactobacillus helveticus strains and reducing food and/or respiratory allergy symptoms
WO2014159609A1 (en) * 2013-03-14 2014-10-02 Allergen Research Corporation Peanut formulations and uses thereof
KR102233251B1 (ko) * 2013-04-03 2021-03-26 엔-폴드 엘엘씨 신규 나노입자 조성물
US20170021010A1 (en) * 2015-07-21 2017-01-26 David Phillip ERSTEIN Allergy preventing dosage controlled food packets
EP3371770A4 (en) * 2015-11-04 2019-04-24 Bayer Healthcare LLC BARCODE DATABASE AND SOFTWARE UPGRADING SYSTEM
EP3440579A4 (en) * 2015-11-24 2020-03-25 Klaritos, Inc. INNOVATIVE MODEL OF DELIVERY, PROCESSING AND PAYMENT FOR SPECIALIZED MEDICINES
US20230190645A1 (en) * 2017-12-06 2023-06-22 Prollergy Corporation Composition and method for reducing allergic response

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8386274B1 (en) * 2008-09-17 2013-02-26 Mckesson Financial Holdings Limited Systems and methods for a prescription safety network utilizing eligibility verification transactions
JP2014509606A (ja) * 2011-03-17 2014-04-21 ケンブリッジ エンタープライズ リミティッド ピーナッツアレルギーの治療
US20130292294A1 (en) * 2012-05-03 2013-11-07 Brandon J. Wilson Allergy emergency kit
JP2016512537A (ja) * 2013-03-14 2016-04-28 アイミューン セラピューティクス，インコーポレイテッド 経口脱感作のための落花生処方物の製造
JP2016521713A (ja) * 2013-06-04 2016-07-25 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． Ｉｌ−４ｒ阻害剤の投与によるアレルギー処置方法およびアレルゲン特異的免疫療法の向上方法

Also Published As

Publication number Publication date
US20210151155A1 (en) 2021-05-20
US20220415464A1 (en) 2022-12-29
CN114981191A (zh) 2022-08-30
CN114981191B (zh) 2025-08-15
AU2020388398A1 (en) 2022-04-21
EP4061753A4 (en) 2023-12-13
EP4061753A1 (en) 2022-09-28
BR112022009664A2 (pt) 2022-08-16
WO2021102186A1 (en) 2021-05-27
CA3162233A1 (en) 2021-05-27

Similar Documents

Publication Publication Date Title
US20230360760A1 (en) Methods of regulating access to qsymia to mitigate potential drug-associated risks
US20190355472A1 (en) Computer-implemented system and methods for predicting the health and therapeutic behavior of individuals using artificial intelligence, smart contracts and blockchain
JP5976059B2 (ja) 薬に禁忌を示すであろう患者による薬へのアクセスを制限しながら患者へ薬を引き渡すための装置、及びその使用方法
Kim et al. Omalizumab: Practical considerations regarding the risk of anaphylaxis
Adams et al. Pharmacists' Patient Care Process: a state “Scope of practice” perspective
US11244744B2 (en) Risk evaluation and management strategy involving patient follow-ups relating to the use or discontinuation of a complement inhibitor
JP2008212629A (ja) 薬剤が禁忌とされる患者の当該薬剤へのアクセスを制限すると同時に、患者に当該薬剤を供給するための方法
Anagnostou et al. The use and implementation of omalizumab as food allergy treatment: Consensus-based guidance and Work Group Report of the Adverse Reactions to Foods Committee of the American Academy of Allergy, Asthma & Immunology
US20170242962A1 (en) Online managed medical portal for patients and physicians
Alvaro‐Lozano et al. Allergic patients during the COVID‐19 pandemic—Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey
JP2023502423A (ja) 食物アレルギー経口免疫療法薬物の配給及び治療を管理する方法及びシステム
US20100256984A1 (en) Method and system to control and enhance prescribing and dispensing of medication
US20210295971A1 (en) Sensitive drug distribution systems and methods
US7885824B1 (en) Method and system for delivering medical therapies
US10412089B2 (en) Device based risk management of a therapeutic
Chiara The expanding role of pharmacists: a positive shift for health care
Omotosho et al. Electronic prescription system for pediatricians
US11755996B2 (en) Method for repurposing NDC codes in a pharmaceutical database for allergens
Schriefer et al. Medication reconciliation in the outpatient primary care setting: Barriers and opportunities
Weissman et al. New Laws That Expand The Role Of The Pharmacist In Patient Care
Babbar et al. Irrational use of drugs–a review
WO2017025812A1 (en) Method for repurposing ndc codes in a pharmaceutical database for venom derived allergens involved in venom immunotherapy
RU2022106556A (ru) Способ обеспечения пациентов с заболеваниями органов дыхания лекарственными препаратами
Hall et al. Patient Care Process
Trygstad FDA, AMA Deem Pharmacists Unsafe for Test and Treat: Will Expansions in Scope of Authority Stick, or Have the Effectiveness and Speed of Pharmacy Adoption of Services Moved the Medical Establishment to Battle Stations?.

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231120

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231120

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20241218

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241224

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250617